Action of solamargine on human lung cancer cells - Enhancement of the susceptibility of cancer cells to TNFs

FEBS Letters

Volumn 577, Issue 1-2, 2004, Pages 67-74

  Liu, Li Feng ^a   Liang, Chia Hua ^b   Shiu, Li Yen ^b   Lin, Wei Ling ^b   Lin, Chih Chao ^b   Kuo, Kou Wha ^b,c  

^a I SHOU UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c Lane 31   (United States)

Author keywords

Apoptosis; Drug resistance; FADD, Fas associated death domain; Lung cancer; PS, phosphatidylserine; SM, solamargine; Solamargine; TNF, tumor necrosis factor; TNFRs, tumor necrosis factor receptors; TRADD, TNFR 1 associated death domain

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN BCL 2; SOLAMARGINE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; BIOASSAY; CANCER CELL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; LUNG CARCINOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL DIVISION; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SOLANACEOUS ALKALOIDS;

SOLANUM; SOLANUM INCANUM;

EID: 7544237949     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2004.09.064     Document Type: Article

References (36)

1. Boring C.C., Squires T.S., Tong T. Cancer statistics. Cancer J. Clin. 43:1993;7-26
2. Ihde D.C. Chemotherapy of lung cancer. N. Engl. J. Med. 327:1992;1434-1441
3. Fokkema E., Groen H.J., Meijer C., Timens W., de Jong S., de Vries E.G. The role of apoptosis-related genes in non-small-cell lung cancer. Clin. Lung Cancer. 4:2002;174-182
4. Fisher D.E. Apoptosis in cancer therapy: crossing the threshold. Cell. 78:1994;539-542
5. Bazzori F., Beutler B. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334:1996;1717-1725
6. Tartaglia L.A., Weber R.F., Figari I.S., Reynolds C., Palldino M.A.J., Goeddel D.V. The two different receptors for TNF mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA. 88:1991;9292-9296
7. Grell M., Zimmermann G., Hulser D., Pfizenmaier K., Scheurich P. TNF receptors TR60 and TR80 can mediate apoptosis via induction of distinct signal pathways. J. Immunol. 153:1994;1963-1972
8. Ohara H., Hasegawa Y., Kawabe T., Ichiyama S., Hara T., Shimono Y., Saito H., Shimokata K. Effect of gene transfer of tumor necrosis factors into human lung carcinoma cell line. J. Cancer Res. 89:1998;589-595
9. Shimomoto H., Hasegawa Y., Nozaki Y., Takagi N., Shibagaki T., Nakao A., Shimokata K. Expression of tumor necrosis factor receptors in human lung cancer cells and normal lung tissues. Am. J. Respir. Cell Mol. Biol. 13:1995;271-278
10. Tran T.A., Kallakury B.V., Ambros R.A., Ross J.S. Prognostic significance of tumor necrosis factors and their receptors in non-small cell lung carcinoma. Cancer. 83:1998;276-282
11. Manna S.K., Aggarwal B.B. All-trans-retinoic acid upregulates TNF receptors and potentiates TNF-induced activation of nuclear factor-kappaB, activated protein-1 and apoptosis inhuman lung cancer cells. Oncogene. 17:2000;2110-2119
12. Gan K.H., Lin C.N., Won S.J. Cytotoxic principles and their derivatives of Formosan Solanum plants. J. Nat. Prod. 56:1993;15-21
13. Alzerreca A., Hart G. Molluscicidal steroid glycoalkaloids possessing stereoisomeric spirosolane structures. Toxicol. Lett. 12:1982;151-155
14. Hu K., Kobayashi H., Dong A., Jing Y., Iwasaki S., Yao X. Antineoplastic agents. III: Steroidal glycosides from Solanum nigrum. Planta Med. 65:1999;35-38
15. Hsu S.H., Tsai T.R., Lin C.N., Yen M.H., Kuo K.W. Solamargine purified from Solanum incanum Chinese herb triggers gene expression of human TNFR I which may lead to cell apoptosis. Biochem. Biophys. Res. Commun. 229:1996;1-5
16. Chang L.C., Tsai T.R., Wang J.J., Lin C.N., Kuo K.W. The rhamnose moiety of solamargine plays a crucial role in triggering cell death by apoptosis. Biochem. Biophys. Res. Commun. 242:1998;21-25
17. Kuo K.W., Hsu S.H., Li Y.P., Lin W.L., Liu L.F., Chang L.C., Lin C.C., Lin C.N., Sheu H.M. Anticancer activity evaluation of the solanum glycoalkaloid solamargine. Triggering apoptosis in human hepatoma cells. Biochem. Pharm. 60:2000;1865-1873
18. Kuo K.W., Lenug M.F.K.L., Lenug W.C. Intrinsic secondary structure of human TNFR-I mRNA influences the determination of gene expression by RT-PCR. Mol. Cell Biochem. 177:1997;1-6
19. Cheng E.H., Wei M.C., Weiler S., Flavell R.A., Mak T.W., Lindsten T., Korsmeyer S.J. BCL-2, BCL-X (L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell. 8:2001;705-711
20. Sawanobori M., Yamaguchi S., Hasegawa M., Inoue M., Suzuki K., Kamiyama R., Hirokawa K., Kitagawa M. Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes. Leuk. Res. 27:2003;583-591
21. Dive C., Gregory C.D., Phipps D.J., Evans D.L., Melner A.E., Wyllie A.H. Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochem. Biophys. Acta. 1133:1992;275-285
22. Splinter T.A. Introduction to the treatment of lung cancer. Sem. Oncol. 24:1997;S121-S125
23. Zhang L., Chang C.J., Bacus S.S., Hung M.C. Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cell by emodin. Cancer Res. 55:1995;3890-3896
24. Thompson C.B. Apoptosis in pathogenesis and genes and treatment of disease. Science. 267:1995;1456-1461
25. Yang S.C., Grimm E.A., Parkinson D.R., Carinhas J., Fry K.D., Mendiguren-Rodriguez A. Clinical and immunomodulatory effects of combination immunotherapy with low dose interleukin 2 and tumor necrosis factor alpha in patients with advance non-small cell lung cancer: a phase I trail. Cancer Res. 51:1991;3669-3676
26. Schiller J.H., Morgan-Ihrig C., Lecitt M.L. Concomitant administration of interleukin-2 plus tumor necrosis factor in advanced non-small cell lung cancer. Am. J. Clin. Oncol. 18:1995;47-51
27. Ohmori T., Podack E.R., Nishio K., Takahashi M., Miyahara Y., Takeda Y., Kubota N., Funayama Y., Ogasawara H., Ohira T. Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2. Biochem. Biophys. Res. Commun. 192:1993;30-36
28. BenEzra J.M., Kornstein M.J., Grimes M.M., Krystal G. Small cell carcinomas of the lung express the Bcl-2 protein. Am. J. Pathol. 145:1994;1036-1040
29. Brambilla E., Negoescu A., Gazzeri S., Lantuejoul S., Moro D., Brambilla C., Coll J.L. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors. Am. J. Pathol. 149:1996;1941-1952
30. Ziegler A., Luedke G.H., Fabbro D., Altmann K.H., Stahel R.A., Zangemeister-Wittke U. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence. J. Natl. Cancer Inst. 16:1997;1027-1036
31. Leech S.H., Olie R.A., Gautschi O., Simoes-Wust A.P., Tschopp S., Haner R., Hall J., Stahel R.A., Zangemeister-Wittke U. Induction of apoptosis in lung-cancer cells following bcl-xL anti-sense treatment. Int. J. Cancer. 15:2000;570-576
32. Zangemeister-Wittke U., Schenker T., Luedke G.H., Stahel R.A. Synergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small-cell lung cancer cell lines. Br. J. Cancer. 78:1998;1035-1042
33. Akiyama S., Chen Z.S., Sumizawa T., Furukawa T. Resistance to cislpatin. Anticancer Drug Des. 14:1999;143-151
34. Yoon S.S., Ahn K.S., Kim S.H., Shim Y.M., Kim J. In vitro establishment of cis-diammine-dichloroplatinum (II) resistance lung cancer cell line and modulation of apoptotic gene expression as a mechanism of resistance phenotype. Lung Cancer. 33:2001;221-228
35. Ferreira C.G., Span S.W., Peters G.J., Kruyt F.A., Giaccone G. Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the non-small cell lung cancer cell line NCI-H460. Cancer Res. 60:2000;7133-7141
36. Carlos G.F., Christos T., Simone W.S., Godefridus J.P., Lopik T., Kummer A.J., Pinedo H.M., Giaccone G. Drug-induced apoptosis in lung cancer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway. Clin. Cancer Res. 6:2000;203-212